Digital health company Healee has raised $2M in a seed round, the company has announced.
The financing was led by Nina Capital, with the participation of Calm/Storm Ventures, KAYA VC and existing investor Eleven Ventures, to fund U.S. expansion and technology development.
Healee’s technology enables healthcare organisations to rapidly launch ready infrastructure for telehealth, digital check-in and scheduling, configured to custom workflows and branding.
Current applications for the technology span traditional healthcare, insurance and pharma, as well as niche services in wellness, behavioural health, chronic and palliative care and COVID consultations.
Hristo Kosev, CEO and founder of Healee, said:
“Healee offers you an advanced, yet easy way to get started with digital health while building your brand and adapting your tool for better user engagement.”
According to a 2022 healthcare industry report by HIMSS, almost 80 per cent of all health systems in the U.S. are still in their planning stages for digital transformation.
The barriers include poor tool fit to organisational workflows and lack of proper customisation, the report revealed.
To help address these barriers, Healee has devised a new “deep white label” solution category.
A Healee-based platform replaces a multitude of existing tools to alleviate digital fatigue and closely fit clinical processes.
Marc Subirats, general partner at Nina Capital, said:
“Healee is prepared for the next disruption wave in virtual care, now driven by the growing need for hybrid or virtual-first care models.
“Healee has taken an enabling technology platform approach to becoming a leader in this wave, with the ability to support any distinct virtual care use case.”
